Ondansetron base api dr reddys api?

What is Ondansetron Base API Dr. Reddy's API?

Dr. Reddy's Laboratories manufactures Ondansetron Base Active Pharmaceutical Ingredient (API) [1]. Ondansetron is a medication used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery [2].

When does Ondansetron's patent exclusivity expire?

Information regarding specific patent expiry dates for Ondansetron API manufactured by Dr. Reddy's is not available in the provided text. However, general patent information and expiry timelines for various drugs can be found on DrugPatentWatch.com [3].

What are the different forms of Ondansetron available?

Ondansetron is available in various formulations, including oral tablets, orally disintegrating tablets, and injectable solutions [2]. These different forms cater to various patient needs and administration preferences.

How does Ondansetron work?

Ondansetron functions by blocking the action of serotonin, a natural substance that can cause nausea and vomiting. By inhibiting serotonin's effects in the brain and gastrointestinal tract, it effectively reduces these symptoms [2].

What are the risks or side effects associated with Ondansetron?

Common side effects of Ondansetron can include headache, constipation, diarrhea, and dizziness [2]. More serious side effects, though less common, may also occur.

Who are the other manufacturers of Ondansetron API?

While Dr. Reddy's Laboratories is a manufacturer of Ondansetron Base API, other pharmaceutical companies also produce this API [1]. The market for essential APIs like ondansetron is competitive, with multiple suppliers globally.

Where can I find more detailed information on drug patents and exclusivity?

For comprehensive data on drug patents, expiry dates, and market exclusivity for pharmaceuticals, DrugPatentWatch.com offers a valuable resource [3].

Sources:

1. https://www.drreddys.com/products/
2. https://www.drugs.com/onda/ondansetron-base.html
3. https://drugpatentwatch.com/